newsfilter
← Latest News
GlobeNewswire·

BiondVax Announces Plan to Implement ADS Ratio Change

JERUSALEM, Nov. 10, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV) ("BiondVax"), a biotechnology company focused on developing, manufacturing, and commercializing innovative